TW202400808A - 偵測突變以用於癌症篩選分析 - Google Patents
偵測突變以用於癌症篩選分析 Download PDFInfo
- Publication number
- TW202400808A TW202400808A TW112132531A TW112132531A TW202400808A TW 202400808 A TW202400808 A TW 202400808A TW 112132531 A TW112132531 A TW 112132531A TW 112132531 A TW112132531 A TW 112132531A TW 202400808 A TW202400808 A TW 202400808A
- Authority
- TW
- Taiwan
- Prior art keywords
- candidate
- dna
- cancer
- mutations
- plasma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562114471P | 2015-02-10 | 2015-02-10 | |
| US62/114,471 | 2015-02-10 | ||
| US201562271196P | 2015-12-22 | 2015-12-22 | |
| US62/271,196 | 2015-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202400808A true TW202400808A (zh) | 2024-01-01 |
Family
ID=56615337
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112132531A TW202400808A (zh) | 2015-02-10 | 2016-02-15 | 偵測突變以用於癌症篩選分析 |
| TW110131934A TWI817187B (zh) | 2015-02-10 | 2016-02-15 | 偵測突變以用於癌症篩選分析 |
| TW105104407A TWI740817B (zh) | 2015-02-10 | 2016-02-15 | 偵測突變以用於癌症篩選及胎兒分析 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110131934A TWI817187B (zh) | 2015-02-10 | 2016-02-15 | 偵測突變以用於癌症篩選分析 |
| TW105104407A TWI740817B (zh) | 2015-02-10 | 2016-02-15 | 偵測突變以用於癌症篩選及胎兒分析 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10240209B2 (enExample) |
| EP (2) | EP3256605B1 (enExample) |
| JP (3) | JP6829211B2 (enExample) |
| KR (1) | KR20170125044A (enExample) |
| CN (2) | CN113957124A (enExample) |
| AU (2) | AU2016218631B2 (enExample) |
| CA (1) | CA2976303A1 (enExample) |
| DK (1) | DK3256605T3 (enExample) |
| ES (1) | ES2908347T3 (enExample) |
| HU (1) | HUE058263T2 (enExample) |
| PT (1) | PT3256605T (enExample) |
| SG (1) | SG11201706529TA (enExample) |
| TW (3) | TW202400808A (enExample) |
| WO (1) | WO2016127944A1 (enExample) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101153336B (zh) | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| US9260753B2 (en) | 2011-03-24 | 2016-02-16 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| EP4036247B1 (en) | 2012-09-04 | 2024-04-10 | Guardant Health, Inc. | Methods to detect rare mutations and copy number variation |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| WO2014093330A1 (en) | 2012-12-10 | 2014-06-19 | Clearfork Bioscience, Inc. | Methods for targeted genomic analysis |
| SG10201804519RA (en) | 2013-12-28 | 2018-07-30 | Guardant Health Inc | Methods and systems for detecting genetic variants |
| TWI895765B (zh) | 2014-07-18 | 2025-09-01 | 香港中文大學 | Dna混合物中之組織甲基化模式分析 |
| KR102696857B1 (ko) | 2014-07-25 | 2024-08-19 | 유니버시티 오브 워싱톤 | 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법 |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| CA2976303A1 (en) | 2015-02-10 | 2016-08-18 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening and fetal analysis |
| HUE057821T2 (hu) | 2015-07-23 | 2022-06-28 | Univ Hong Kong Chinese | Sejtmentes DNS fragmentációs mintázatának elemzése |
| CN108431233B (zh) | 2015-11-11 | 2022-04-01 | 分析生物科学有限公司 | Dna文库的高效率构建 |
| CN117174167A (zh) | 2015-12-17 | 2023-12-05 | 夸登特健康公司 | 通过分析无细胞dna确定肿瘤基因拷贝数的方法 |
| US11514289B1 (en) | 2016-03-09 | 2022-11-29 | Freenome Holdings, Inc. | Generating machine learning models using genetic data |
| EP3427183A1 (en) * | 2016-03-10 | 2019-01-16 | Genomic Vision | Method of curvilinear signal detection and analysis and associated platform |
| CN116445593A (zh) | 2016-08-10 | 2023-07-18 | 格里尔公司 | 测定一生物样品的一甲基化图谱的方法 |
| AU2017315769B2 (en) | 2016-08-25 | 2024-02-01 | Resolution Bioscience, Inc. | Methods for the detection of genomic copy changes in DNA samples |
| WO2018064629A1 (en) | 2016-09-30 | 2018-04-05 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| EP3535415A4 (en) | 2016-10-24 | 2020-07-01 | The Chinese University of Hong Kong | TUMOR DETECTION METHODS AND SYSTEMS |
| IL315032A (en) | 2016-11-30 | 2024-10-01 | Univ Hong Kong Chinese | Analysis of cell-free dna in urine and other samples |
| WO2018119216A1 (en) * | 2016-12-21 | 2018-06-28 | The Regents Of The University Of California | Deconvolution and detection of rare dna in plasma |
| CA3051509A1 (en) * | 2017-01-25 | 2018-08-02 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
| EP3366780B1 (en) | 2017-02-23 | 2020-05-06 | Siemens Healthcare GmbH | Single-molecule sequence and high sensitivity methylation analysis for tissue-specific analysis |
| IT201700045353A1 (it) * | 2017-04-26 | 2018-10-26 | Bioscience Services S R L | Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi |
| CN110914450B (zh) * | 2017-05-16 | 2024-07-02 | 夸登特健康公司 | 无细胞dna的体细胞来源或种系来源的鉴定 |
| US10081829B1 (en) | 2017-06-13 | 2018-09-25 | Genetics Research, Llc | Detection of targeted sequence regions |
| US10636512B2 (en) | 2017-07-14 | 2020-04-28 | Cofactor Genomics, Inc. | Immuno-oncology applications using next generation sequencing |
| EP3431610A1 (en) * | 2017-07-19 | 2019-01-23 | Noscendo GmbH | Methods and devices for nucleic acid-based real-time determination of disease states |
| JP7776099B2 (ja) | 2017-07-26 | 2025-11-26 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 無細胞ウイルス核酸を用いる癌スクリーニングの強化 |
| US20190108311A1 (en) * | 2017-10-06 | 2019-04-11 | Grail, Inc. | Site-specific noise model for targeted sequencing |
| EP3704268B1 (en) | 2017-11-03 | 2025-01-22 | Guardant Health, Inc. | Normalizing tumor mutation burden |
| JP7299169B2 (ja) * | 2017-12-01 | 2023-06-27 | イルミナ インコーポレイテッド | 体細胞突然変異のクローン性を決定するための方法及びシステム |
| MY201935A (en) | 2018-01-12 | 2024-03-25 | Grail Inc | Methods for analyzing viral nucleic acid |
| DE202019005627U1 (de) | 2018-04-02 | 2021-05-31 | Grail, Inc. | Methylierungsmarker und gezielte Methylierungssondenpanels |
| US20210158895A1 (en) * | 2018-04-13 | 2021-05-27 | Dana-Farber Cancer Institute, Inc. | Ultra-sensitive detection of cancer by algorithmic analysis |
| CN112218957B (zh) * | 2018-04-16 | 2025-08-08 | 格里尔公司 | 用于确定在无细胞核酸中的肿瘤分数的系统及方法 |
| TW202012639A (zh) * | 2018-04-24 | 2020-04-01 | 美商格瑞爾公司 | 使用病原體核酸負荷確定個體是否患有癌症病況的系統及方法 |
| CN108900319B (zh) * | 2018-05-30 | 2021-05-25 | 北京百度网讯科技有限公司 | 故障检测方法和装置 |
| CA3107983A1 (en) * | 2018-07-23 | 2020-01-30 | Guardant Health, Inc. | Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage |
| WO2020023671A1 (en) * | 2018-07-24 | 2020-01-30 | Protocol Intelligence, Inc. | Methods and systems for treating cancer and predicting and optimizing treatment outcomes in individual cancer patients |
| SG11202100570YA (en) | 2018-07-26 | 2021-02-25 | Lexent Bio Inc | Multiple sequencing using a single flow cell |
| CN109022619A (zh) * | 2018-08-27 | 2018-12-18 | 郑州安图生物工程股份有限公司 | 一种用于检测人类疱疹病毒4型的试剂盒 |
| AU2019351130B2 (en) | 2018-09-27 | 2025-10-23 | GRAIL, Inc | Methylation markers and targeted methylation probe panel |
| EP3881323A4 (en) * | 2018-11-13 | 2022-11-16 | Myriad Genetics, Inc. | METHODS AND SYSTEMS FOR SOMATIC MUTATIONS AND USES THEREOF |
| TW202536188A (zh) * | 2018-12-19 | 2025-09-16 | 香港中文大學 | 游離dna末端特徵 |
| ES3013495T3 (en) | 2019-01-31 | 2025-04-14 | Guardant Health Inc | Method for isolating and sequencing cell-free dna |
| CN109841265B (zh) * | 2019-02-22 | 2021-09-21 | 清华大学 | 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用 |
| US12497662B2 (en) | 2019-04-16 | 2025-12-16 | Grail, Inc. | Systems and methods for tumor fraction estimation from small variants |
| US20220243279A1 (en) * | 2019-05-20 | 2022-08-04 | Foundation Medicine, Inc. | Systems and methods for evaluating tumor fraction |
| CN112823391B (zh) * | 2019-06-03 | 2024-07-05 | Illumina公司 | 基于检测限的质量控制度量 |
| EP3987522A1 (en) * | 2019-06-21 | 2022-04-27 | CooperSurgical, Inc. | Systems and methods for using density of single nucleotide variations for the verification of copy number variations in human embryos |
| WO2021016441A1 (en) * | 2019-07-23 | 2021-01-28 | Grail, Inc. | Systems and methods for determining tumor fraction |
| EP4020484A4 (en) * | 2019-08-19 | 2023-08-30 | Green Cross Genome Corporation | METHOD FOR DETECTING A CHROMOSOME ABNORMALITY USING INFORMATION CONCERNING THE DISTANCE BETWEEN NUCLEIC ACID FRAGMENTS |
| JP7705797B2 (ja) * | 2019-10-08 | 2025-07-10 | イルミナ インコーポレイテッド | クローン性造血由来の無細胞ｄｎａ変異の断片サイズ特性評価 |
| WO2021137770A1 (en) * | 2019-12-30 | 2021-07-08 | Geneton S.R.O. | Method for fetal fraction estimation based on detection and interpretation of single nucleotide variants |
| AU2021205853A1 (en) * | 2020-01-08 | 2023-11-23 | Grail, Inc. | Biterminal dna fragment types in cell-free samples and uses thereof |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| AU2021395060A1 (en) * | 2020-12-08 | 2023-07-06 | Grail, Llc | Methods using characteristics of urinary and other dna |
| CN113628683B (zh) * | 2021-08-24 | 2024-04-09 | 慧算医疗科技（上海）有限公司 | 一种高通量测序突变检测方法、设备、装置及可读存储介质 |
| WO2023129983A1 (en) * | 2021-12-29 | 2023-07-06 | AiOnco, Inc. | Processing encrypted data for artificial intelligence-based analysis |
| CN114582429B (zh) * | 2022-03-03 | 2023-06-13 | 四川大学 | 基于层次注意力神经网络的结核分枝杆菌耐药性预测方法及装置 |
| KR102491322B1 (ko) * | 2022-03-29 | 2023-01-27 | 주식회사 아이엠비디엑스 | 암 진단을 위한 다중 분석 예측 모델의 제조 방법 |
| EP4526481A2 (en) * | 2022-05-19 | 2025-03-26 | Personalis, Inc. | Methods and system for using methylation data for disease detection and quantification |
| CN115394358B (zh) * | 2022-08-31 | 2023-05-12 | 西安理工大学 | 基于深度学习的单细胞测序基因表达数据插补方法和系统 |
| EP4567818A4 (en) * | 2022-09-09 | 2025-12-17 | Nanjing Genscript Biotech Co Ltd | METHOD FOR DESIGNING A SEQUENCE OF HUMANIZED ANTIBODY |
| CN115424666B (zh) * | 2022-09-13 | 2023-07-11 | 江苏先声医学诊断有限公司 | 一种基于全基因组重亚硫酸盐测序数据筛选泛癌早筛分子标志物的方法及系统 |
| JP7736308B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736310B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736309B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736307B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| EP4649174A2 (en) * | 2023-01-09 | 2025-11-19 | ClearNote Health, Inc. | 5-hydroxymethylation analysis of buffy coat gdna in cancer detection |
| WO2025054456A1 (en) * | 2023-09-08 | 2025-03-13 | Ellison Institute, Llc | Methods of determining variability in molecular alterations |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2369578A1 (en) | 1999-04-02 | 2000-10-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US20030219765A1 (en) | 2000-03-23 | 2003-11-27 | Jose Costa | Methods for evaluating cancer risk |
| US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
| US7704687B2 (en) | 2002-11-15 | 2010-04-27 | The Johns Hopkins University | Digital karyotyping |
| EP1599608A4 (en) | 2003-03-05 | 2007-07-18 | Genetic Technologies Ltd | Identification of fetal DNA and fetal cell marker in maternal plasma or serum |
| PL201608B1 (pl) | 2003-06-13 | 2009-04-30 | Cezary Cybulski | Sposób i zestaw do wykrywania wysokiej genetycznie uwarunkowanej predyspozycji do raka prostaty oraz zastosowanie zmiany germinalnej w obrębie genu NBS1 |
| DE60328193D1 (de) | 2003-10-16 | 2009-08-13 | Sequenom Inc | Nicht invasiver Nachweis fötaler genetischer Merkmale |
| WO2005108621A1 (en) | 2004-04-30 | 2005-11-17 | Yale University | Methods and compositions for cancer diagnosis |
| US20070122823A1 (en) | 2005-09-01 | 2007-05-31 | Bianchi Diana W | Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis |
| SI2385143T1 (sl) | 2006-02-02 | 2016-11-30 | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel | Neinvazivni genetski presejalni test ploda z digitalno analizo |
| ATE508209T1 (de) | 2006-02-28 | 2011-05-15 | Univ Louisville Res Found | Erkennung von chromosomabnormalitäten im fötus mit hilfe der tandem-einzelnukleotid- polymorphismen |
| WO2008024009A1 (en) | 2006-08-15 | 2008-02-28 | Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) | Transcriptional level of a timp3 gene in the form of a diagnosis marker of a non-small cell carcinoma of lung |
| EP2535425A1 (en) | 2007-05-25 | 2012-12-19 | Decode Genetics EHF. | Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein |
| KR102222378B1 (ko) | 2007-07-23 | 2021-03-04 | 더 차이니즈 유니버시티 오브 홍콩 | 핵산 서열 불균형의 결정 |
| US20090053719A1 (en) | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
| US20100041048A1 (en) | 2008-07-31 | 2010-02-18 | The Johns Hopkins University | Circulating Mutant DNA to Assess Tumor Dynamics |
| CA2737643C (en) | 2008-09-20 | 2020-10-06 | Hei-Mun Fan | Noninvasive diagnosis of fetal aneuploidy by sequencing |
| US20100136560A1 (en) | 2008-12-02 | 2010-06-03 | The Johns Hopkins University | Integrated Analyses of Breast and Colorectal Cancers |
| US20120021428A1 (en) | 2009-03-31 | 2012-01-26 | Marcus Otte | Method for diagnosis of cancer and monitoring of cancer treatments |
| CA2775671A1 (en) | 2009-10-02 | 2011-04-07 | Centre For Addiction And Mental Health | Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids |
| WO2011053790A2 (en) | 2009-10-30 | 2011-05-05 | Fluidigm Corporation | Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis |
| HUE061110T2 (hu) | 2009-11-05 | 2023-05-28 | Univ Hong Kong Chinese | Magzati genomelemzés anyai biológiai mintából |
| WO2011054936A1 (en) | 2009-11-06 | 2011-05-12 | The Chinese University Of Hong Kong | Size-based genomic analysis |
| GB0922006D0 (en) | 2009-12-17 | 2010-02-03 | Genome Res Ltd | Diagnostic |
| EP2848704B1 (en) | 2010-01-19 | 2018-08-29 | Verinata Health, Inc | Sequencing methods for prenatal diagnoses |
| EP2513341B1 (en) | 2010-01-19 | 2017-04-12 | Verinata Health, Inc | Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing |
| WO2011103236A2 (en) | 2010-02-18 | 2011-08-25 | The Johns Hopkins University | Personalized tumor biomarkers |
| EP2426217A1 (en) | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| KR101891847B1 (ko) | 2010-11-30 | 2018-08-24 | 더 차이니즈 유니버시티 오브 홍콩 | 암과 연관된 유전적 또는 분자적 이상들의 검출 |
| CA2840418C (en) | 2011-07-26 | 2019-10-29 | Verinata Health, Inc. | Method for determining the presence or absence of different aneuploidies in a sample |
| WO2013052913A2 (en) | 2011-10-06 | 2013-04-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2013086352A1 (en) | 2011-12-07 | 2013-06-13 | Chronix Biomedical | Prostate cancer associated circulating nucleic acid biomarkers |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| WO2013138510A1 (en) | 2012-03-13 | 2013-09-19 | Patel Abhijit Ajit | Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing |
| KR20150028256A (ko) | 2012-05-31 | 2015-03-13 | 스미토모 덴키 고교 가부시키가이샤 | 산화물 초전도 박막과 그의 제조 방법 |
| US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| EP4036247B1 (en) * | 2012-09-04 | 2024-04-10 | Guardant Health, Inc. | Methods to detect rare mutations and copy number variation |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| LT3354747T (lt) | 2012-09-20 | 2021-04-12 | The Chinese University Of Hong Kong | Neinvazinis naviko metilomos nustatymas iš plazmos |
| EP2959016A4 (en) * | 2013-02-21 | 2016-10-12 | Toma Biosciences Inc | METHOD, COMPOSITIONS AND NUCLEIC ACID ANALYSIS KITS |
| AU2014233373B2 (en) | 2013-03-15 | 2019-10-24 | Verinata Health, Inc. | Generating cell-free DNA libraries directly from blood |
| US10174375B2 (en) * | 2013-09-20 | 2019-01-08 | The Chinese University Of Hong Kong | Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases |
| US10262755B2 (en) * | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| US20160002717A1 (en) | 2014-07-02 | 2016-01-07 | Boreal Genomics, Inc. | Determining mutation burden in circulating cell-free nucleic acid and associated risk of disease |
| KR102696857B1 (ko) | 2014-07-25 | 2024-08-19 | 유니버시티 오브 워싱톤 | 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법 |
| EP3224380A1 (en) | 2014-11-25 | 2017-10-04 | The Broad Institute Inc. | Clonal haematopoiesis |
| AU2015357573B2 (en) | 2014-12-05 | 2022-04-07 | Foundation Medicine, Inc. | Multigene analysis of tumor samples |
| GB2552267B (en) | 2014-12-31 | 2020-06-10 | Guardant Health Inc | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| CA2976303A1 (en) | 2015-02-10 | 2016-08-18 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening and fetal analysis |
| CA2980078C (en) | 2015-03-16 | 2024-03-12 | Personal Genome Diagnostics Inc. | Systems and methods for analyzing nucleic acid |
-
2016
- 2016-02-14 CA CA2976303A patent/CA2976303A1/en active Pending
- 2016-02-14 KR KR1020177025432A patent/KR20170125044A/ko active Pending
- 2016-02-14 WO PCT/CN2016/073753 patent/WO2016127944A1/en not_active Ceased
- 2016-02-14 EP EP16748745.3A patent/EP3256605B1/en active Active
- 2016-02-14 DK DK16748745.3T patent/DK3256605T3/da active
- 2016-02-14 HU HUE16748745A patent/HUE058263T2/hu unknown
- 2016-02-14 SG SG11201706529TA patent/SG11201706529TA/en unknown
- 2016-02-14 EP EP21205562.8A patent/EP4012715B1/en active Active
- 2016-02-14 PT PT167487453T patent/PT3256605T/pt unknown
- 2016-02-14 ES ES16748745T patent/ES2908347T3/es active Active
- 2016-02-14 JP JP2017559756A patent/JP6829211B2/ja active Active
- 2016-02-14 CN CN202111196156.8A patent/CN113957124A/zh active Pending
- 2016-02-14 AU AU2016218631A patent/AU2016218631B2/en active Active
- 2016-02-14 CN CN201680009446.8A patent/CN107771221B/zh active Active
- 2016-02-15 TW TW112132531A patent/TW202400808A/zh unknown
- 2016-02-15 TW TW110131934A patent/TWI817187B/zh active
- 2016-02-15 TW TW105104407A patent/TWI740817B/zh active
- 2016-11-28 US US15/362,631 patent/US10240209B2/en active Active
-
2019
- 2019-01-22 US US16/254,492 patent/US11168370B2/en active Active
-
2021
- 2021-01-21 JP JP2021007944A patent/JP7168247B2/ja active Active
- 2021-10-29 US US17/514,902 patent/US20220127683A1/en active Pending
-
2022
- 2022-05-10 AU AU2022203114A patent/AU2022203114A1/en not_active Abandoned
- 2022-10-17 JP JP2022166050A patent/JP2022185149A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7168247B2 (ja) | 癌スクリーニング及び胎児分析のための変異検出 | |
| JP6985753B2 (ja) | 血漿による胎児または腫瘍のメチロームの非侵襲的決定 | |
| TWI797095B (zh) | 腫瘤檢測之方法及系統 | |
| US12098429B2 (en) | Determining linear and circular forms of circulating nucleic acids | |
| HK40076095A (en) | Detecting mutations for cancer screening and fetal analysis | |
| TWI901957B (zh) | 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 | |
| HK1244515B (en) | Detecting mutations for cancer screening and fetal analysis | |
| HK1251018B (zh) | 用於癌症筛查和胎儿分析的突变检测 |